Because of their central role in initiating immune responses, dendritic cells (DC) are considered to be a pivotal target for the induction of transplantation tolerance. We studied 2 differentially modulated DC for their capacity to induce regulatory T cells.
A variety of algorithms have been successful in predicting HLA-peptide binding for HLA variants, for which plentiful experimental binding data exists. While predicting binding for only the most common HLA variants may provide suffi cient population coverage for vaccine design, successful prediction for as many HLA variants as possible is necessary to understand the immune response in transplantation. The high cost of peptide sequencing limits the acquisition of binding data. A prediction algorithm, which applies the binding information from well studied HLA variants to HLA variants, for which no peptide data exist, is necessary. To this end, we have developed a modular concept of HLA-peptide binding prediction. Highly accurate predictions were made for the following alleles without using experimental peptide binding data specifi c to those alleles: A*0201, A*0206, A*0214, B*2705, B*3501, B*5102, B*5301. Using the MHCBN peptide database, and a minimum cutoff of 15 peptides, the modular concept increases the number of predictable alleles from 15 (4.5%) to 75 (22.3%) of HLA-A and 12 (2.0%) to 36 (5.9%) of HLA-B proteins. Under the modular concept, binding data of certain HLA molecules can make prediction possible for numerous additional HLA alleles. In this regard, the HLA molecules A*7401, 3201, 6813; B*1803, 4103, 3908 have been identifi ed to be the most informative. Achieving peptide binding prediction for all HLA molecules will provide a major basis for individualizing the clinical application of the minor histocompatibility concept and the management of Graft versus Leukemia reactions.
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UP REGULATION OF HLA CLASS I UNDER G INTERFERON (IFN) DEPENDS ON CD99
Sylvie Coito, Ophelie Meynet, Aurore Bremond, Alain Bernard, Ghislaine Bernard INSERM U 576, Hopital de l'Archet I, route de Saint Antoine de Ginestiere, 06202 Nice, France CD99 is a 32kd transmembrane molecule which belongs to a new family of proteins .We describe here that CD99 powerfully regulates the level of HLA class I. The expression of HLA class I is tightly linked to the surface of variants from the same cell line ; CD99 negative cells (CD99 neg) display a level of class I reduced by half as compared to wild type (wt) cells. After CD99 cDNA transfection, HLA class I expression was fully recovered. Strikingly, gIFN lead to an up-regulation of class I expression on CD99 neg cells two fold less important compared to the increase of class I expression on CD99 retransfected cells. Of note, gIFN did not affect CD99 expression. We have observed, using confocal microscopy that, contrary to CD99 positive cells, HLA class I molecules were stored in the cytoplasmic vesicules and less exported to the cell surface in CD99 neg cells. Yet, we observed no modifi cation of the transcription level of the antigen processing machinery genes.
Our observations might be relevant to tumor and virus escape since loss or down regulation of HLA class I molecules is an important feature which keep tumors and virus infected cells below the cytotoxic T-cell detection levels.
Abstract Session I -KIR
1EFS Nantes, 2U396, Paris, 3EFS Saint-Etienne, 4EFS Poitiers, 5EFS Strasbourg, 6EFS Lyon, 7Saint-Louis, Paris, 8EFS Grenoble, 9EFS Nancy, 10EFS Marseille, 11FGM, Paris, FRANCE Killer immunoglobulin-like receptors (KIR) are expressed on Natural Killer (NK) cells and a subpopulation of CD8 T lymphocytes. Failure to recognize the appropriate KIR ligand (HLA molecules) on a HLA class I mismatched cell may trigger NK cell alloreactivity. Because KIR and HLA genes are located on different chromosomes, matching for HLA genes mostly does not result in matched KIR genes in HLA identical hematopoietic stem cell transplantation (HSCT). In this context, we have retrospectively analysed KIR gene disparities in 174 donor-recipient pairs from HLA-matched unrelated HSCT performed for lymphoid and myeloid malignant diseases in 9 French centers from 1993 to 2003. Genotyping of inhibitory (2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 3DL1, 3DL2, 3DL3) and activating (2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DS1) KIR genes was performed using a PCR-SSP method. In an univariate analysis, we found that donor-recipient mismatching for 2DS1 or 2DS5 (namely activating KIR genes) was associated with the higher incidence of acute GvHD II-IV (p=0.05 and p=0.03 respectively). In the same way, cumulative mismatches for activating KIR genes (2DS1, 2DS2, 2DS3, 2DS4, 2DS5 and 3DS1) statistically increased aGvHD risk (p=0.02, grades 0-I vs II-IV). Moreover, analysis of KIR gene disparities on overall survival showed that donor-recipient pairs mismatched for the inhibitory KIR3DL1 gene were associated with decreased survival (p=0.02). Overall, our results suggest a detrimental effect of a few KIR gene incompatibilities (mainly activating KIR genes) that should be avoided in HLA identical unrelated HSCT. Aim: It has been shown that KIR/HLA incompatibility exerts benefi cial effects in bone marrow transplantation resulting in lower risk from relapse and GvHD. Despite the knowledge about recipient NK-cell cytotoxicity against the graft in renal transplantation, little is known about the role of KIR/Ligand incompatibility in this transplant setting.
Methods: We designed a PCR-SSP strategy for genotyping of 16 KIR genes comprising 18 primer mixes amplifying gene products ranging from 107-455bp. Genotyping for HLA was performed routinely prior to Tx. In our study group 42/94 patients suffered from one or more biopsy proven acute rejection (aRx) episodes after renal transplantation.
Results: Data were analyzed for those KIR genes with known HLA ligand. Non rejecting patients demonstrate a signifi cant higher number for KIR/HLA alleles matches compared to the aRx group. This is observed for both inhibitory and activating KIR receptors (p<0.01, chi-squared test), respectively. Especially the analysis of the mismatch between the inhibitory receptor KIR2DL1 and the corresponding HLA-C group 2 alleles demonstrated an association with aRx (p<0.01).
Conclusion: Although our patient number is low, these are the fi rst data illustrating the functional infl uence of KIR/HLA incompatibility in renal transplantation suggesting that allografts, which do not express recipient MHC class I molecules, can be potential targets for NK-cell killing with consequences for the graft outcome. Natural Killer (NK) cells play a key role in defense against tumor cells that have the capacity to downregulate Human Leukocyte Antigen (HLA) class I expression. It has been reported that leukemic cells can have downregulated expression of HLA class I molecules. Apparently, the NK cells of these patients are not able to destroy these leukemic cells and may allow malignant cells to escape from innate immune control. This failure may be due to the fact that NK cells are part of the malignant clone and therefore might have a decreased function. An alternative hypothesis could be that these patients may display a NK cell Receptor (NKR) genotype incapable of destroying leukemic cells with aberrant expression of HLA class I molecules. The polymorphic nature of these NKR genes generates diverse repertoires in the human population, which display specifi city in the innate immune response.
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DBLRC-KIR, A NEW SPECIALISED DATABASE FOR GENES
In the present study, 11 Killer cell Immunoglobulin-like Receptors (KIRs) and 2 CD94/NKG2 receptors were genotyped by PCR-SSP in 96 leukemic patients and 148 healthy Caucasians.
In conclusion, we report a signifi cant increased frequency of the more inhibitory AB KIR genotype in leukemic patients compared to the controls (31.1% in healthy controls vs. 51.0% in leukemic patients, Pc = 0.002), which is related to the high prevalence of the inhibitory KIR2DL2 in this population (Pc = 0.007). Moreover, two specifi c KIR genotypes AB1 and AB9, including all inhibitory KIRs, were signifi cantly associated with leukemic patients. Our study suggests that an important percentage of leukemic patients express a KIR genotype in favor of escape from NK cell immunity.
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MECHANISM OF INTERACTION BETWEEN NATURAL KILLER CELLS AND FIBROBLASTS IN GRAFT VS HOST DISEASE
Amal Bishara1, Nedal Mohana1, Chaim Brautbar1,2 and Arnon Nagler3 1Tissue Typing Unit, 2Lautenberg Center for General and Tumor Immunology, and 3Dept. of Bone Marrow Transplantation, Hadassah Hebrew University Medical Center, Jerusalem, Israel Natural killer (NK) cells may have dual role post bone marrow transplantation (BMT); promote hemopoeisis and graft vs leukemia effect and/or have a role in graft vs host disease (GVHD). In an attempt to clarify the role of NK cells in GVHD, we designed an in vitro system in which we cultured NK cells from GVHD patients with primary skin fi broblast and followed the interactions that took place between the NK cells and the fi broblasts. NK cells from GVHD but not from GVHD-free patients adhered to the fi broblast in an active process that required energy and involvement of both types of cells, since it did not occur at 4°C and when one or both types of cells were treated with formaldehyde prior to co-culturing. The adherence of NK cells to the fi broblasts resulted in induction of ICAM1and alteration in CD44 expression on the fi broblast cell surface, and in fusion between both types of cells. The adhesion molecules CD44 and ICAM-1 accumulated in the contact areas between NK cells and fi broblasts. Anti CD44 but not anti ICAM-1 inhibits the adherence of NK cells to the fi broblasts, indicting a role for ICAM-1 in stabilizing rather than initiating the adherence process. NK cells express two typical cell surface markers; CD56 and CD16. Antibodies against CD16 and not CD56 inhibit the adherence of NK cells to the fi broblasts. In summary, NK cells from GVHD patients adhere to skin fi broblasts in culture; CD44 and CD16 participate in this interaction.
KILLER INHIBITORY RECEPTORS (KIR) MISMATCHING AND LIVER TRANSPLANTATION OUTCOME
Amal Bishara1, Chaim Brautbar1,2, Gidon Zamir3, Ahmed Eid3 and Rifaat Safadi4 1Tissue typing Unit, 2Lautenberg Center for General and Tumor Immunology, Dept. of 3Surgery, 4Liver and Gastroenterology Units, Division of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Occurrence of graft rejection episodes following Orthoptic liver transplantation (OLT) despite anti-T-lymphocyte immunosuppressive therapy is indicating the involvement of other mechanisms/cells. Activity of NK cells and their Killer Ig like receptors (KIR) is regulated by HLA-Class-I determinants. As recipient/donor pairs are usually HLA-class-I mismatched, NK alloreactivity within recipients might emerge towards rejection. In this retrospective study we analyzed rejection occurrence and outcome of 55 OLT recipients, 38 with and 17 without potential NK alloreactivity to the rejection direction. Recipients with potential NK alloreactivity signifi cantly experienced more rejection episodes as compared to the group with matched donor/recipient epitopes. Moreover, this effect was more profound when the outcome was analyzed in OLT recipients across negative cross match for the anti-HLA class-I and II antibodies (P=0.07). Disparity for C epitopes in rejection direction had more impact on the outcome than that of Bw epitopes (P=0.012 vs. P=0.43). In conclusion, NK alloreactivity and especially HLA-C mismatch may infl uence outcome post OLT.
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KIR2DL4 GENE POLYMORPHISM IDENTIFIED BY SEQUENCING BASED TYPING (KIR-SBT) AND THE CONSTRUCTION OF ITS ALLELE DATABASE FOR DIRECT SEQUENCE ANALYSIS
Jennifer Schellekens, Jessica Wijbenga, Erik H. Rozemuller, Marcel G. J. Tilanus Department of Pathology, University Medical Centre, Postbus 85500, 3508 GA, Utrecht, The Netherlands
The killer cell immunoglobulin like receptors (KIR) on natural killer (NK) cells recognize defi ned groups of HLA class I alleles. By this mechanism the NK cells fulfi ll a signifi cant role in the fi rst line of defence against for example infectious agents and cancer. This allorecognition is important in the treatment of leukemia. For an appropriate effect against the leukemic cells, the expression level of both the KIR as the HLA molecule is of enormous impact. It is known that polymorphisms in the KIR gene may cause an altered expression of this KIR on the membrane. We studied the KIR2DL4 gene polymorphism by a newly developed direct sequencing (SBT) protocol. The absence of a descent database for KIR sequence analysis is a distinct problem. To facilitate routine KIR high resolution typing, and to gain insight in all polymorphic positions in the KIR2DL4 gene, we created a database that combined the exon ánd intron information with the current knowledge of the polymorphic positions. New polymorphisms, insertion and deletions have been characterized in 16 individuals. The routine SBT protocol is currently extended to other KIR genes and generation of the appropriate databases allows routine KIR SBT typing. Intention: MHC class I chain-related antigens (MICA) are polymorphic stress-regulated molecules which have been shown to be expressed on e.g. epithelial, endothelial cells and activated CD4+ and CD8+ T cells. MICA binds to NKG2D, an activating natural cytotoxicity receptor (NCR). Acute rejection (aRx) following renal transplantation implicates cellular stress within the graft. To assess whether an induction of MICA antigen leads to an enhanced activation of NKG2D during aRx, we examined mRNA profi les of both markers in biopsies and urine sediment during aRx. Material and Methods: Using real-time RT-PCR 21 biopsy samples diagnosed as aRx were investigated for MICA and NKG2D mRNA expression and were compared to control biopsies (n=18). In a second patient group urine samples were collected from renal-allograft rejecting recipients (n=27) during aRx and compared to 27 patients with stable renal function. Results: The analysis revealed a signifi cant mRNA upregulation of NKG2D (p<0.001) in biopsies diagnosed as aRx compared to the controls. ROC curve analysis for NKG2D demonstrated a sensitivity and specifi city of 81% and 70%. Highly mRNA induction particularly for the NK cell receptor NKG2D (p<0.01) and MICA (p<0.05) was uncovered in urine sediment in patients with aRx. Conclusion: Our data describe the simultaneous and signifi cant mRNA expression of MIC and NKG2D during renal aRx, supporting previous studies showing MICA as an important antigen target. The interaction of both molecules may potentially enhance innate NK cell responses during renal allograft aRx.
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CTLA-4 POLYMORPHISM COULD INFLUENCE SURVIVAL IN HLA-IDENTICAL SIBLING BONE MARROW TRANS-PLANTATIONS (BMT)
Pascale Loiseau1, 2, Chun. Chen1, Marc Busson2, Virginia Lepage1, 2, Eliane Gluckman3, Gérard Socié3, Vanderson Rocha3, Antoine Toubert1, 2, and Dominique Charron1, 2 1Service d'Immunologie et d'Histocompatibilité, 2INSERM U662, 3Unité de greffe de moelle, Hôpital Saint-Louis, Paris, France CTLA-4 functions as a negative regulator of T-cell response by competing with CD28 for the receptors. A newly identifi ed SNP, A6230G, in the 3'fl anking region of CTLA-4 was found to be highly associated with Graves'disease. It was proposed that the A6230G SNP could determine the production of soluble CTLA-4 and by this way could modulate the T-cell self-reactivity.
In order to evaluate the impact of A6230G polymorphism on BMTs, we have analysed A6230G genotypes in 183 donor-recipient pairs from HLAmatched sibling BMTs performed for malignant (156 cases) and for non malignant diseases (27 cases).
Patients were transplanted with unmanipulated BM using a myeloablative conditioning regimen.
The A6230G genotypes observed were AA in 22% and 19%, AG in 44% and 49%, and GG in 34% and 32% of recipients and donors respectively. These frequencies are in accordance with those published. Although not signifi cant, we observed a trend towards an increased risk of moderate to severe acute GVHD in GG patients compared to others (50% versus 38%). We also observed a signifi cant increased incidence of bacterial infections (p=0.01), a higher risk of infections (p=0.05) and a poorer overall survival rate (p=0.06) in AA patients.
Conclusion: CTLA-4 polymorphism could infl uence survival in HLAidentical sibling BMT perhaps through its impact on infection occurrence.
